The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2018

Filed:

Mar. 16, 2016
Applicant:

The Regents of the University of Colorado, a Body Corporate, Denver, CO (US);

Inventors:

Kunhua Song, Centennial, CO (US);

Yuanbiao Zhao, Denver, CO (US);

Pilar Londono, Highlands Ranch, CO (US);

Timothy McKinsey, Broomfield, CO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/077 (2010.01); A61K 48/00 (2006.01); A61K 31/713 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0657 (2013.01); A61K 31/713 (2013.01); A61K 38/1709 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); C12N 2501/15 (2013.01); C12N 2501/60 (2013.01); C12N 2501/65 (2013.01); C12N 2501/727 (2013.01); C12N 2501/73 (2013.01); C12N 2501/999 (2013.01); C12N 2506/1307 (2013.01);
Abstract

Pro-fibrotic signaling potently antagonizes cardiac reprogramming. Inhibition of pro-fibrotic signaling using small molecules that target the transforming growth factor-β/SMAD, or Rho kinase leads to conversion of approximately 60% of fibroblasts into beating cardiomyocytes. Conversely, over-activation of these pro-fibrotic signaling networks inhibits cardiac reprogramming. Using the disclosed methods, fibroblasts are converted to spontaneously contracting cardiomyocytes in less than two weeks.


Find Patent Forward Citations

Loading…